Affiliation:
1. G.N. Gabrichevsky Research Institute for Epidemiology and Microbiology
2. The First Sechenov Moscow State Medical University
Abstract
The published during last few years data concerning communicative role of lectins (proteins and their complexes which recognize carbohydrates, glycoconjugates and their patterns) in on-duty supporting and increasing anticancer status of human immunity are analyzed. Examples of lectin-(glycoconjugate pattern) strategies, approaches and tactic variants in study and development of anticancer treatments, principle variants of therapy, possible vaccines in 35 cases of blood connected tumors (leukemia, lymphomas, others), solid tumors (carcinomas, sarcoma, cancers of vaginal biotopes, prostate, bladder, colon, other intestinal compartments, pancreas, liver, kidneys, others) and cancer cell lines are described and systemized. The list of mostly used communicative lectins (pattern recognition receptors, their soluble forms, other soluble lectins possessing specificities of importance) involving in key intercellular cascades and pathway co-functioning is presented. The regulation of resulting expression of distinct active lectins (available and hetero/di/oligomeric forms) and their interaction to adequate glycoconjugate patterns as well as influence distribution of co-functioning lectins and antigens CD between populations and subpopulations of antigen-presented cells (dendritic cells cDC, mDC, moDC, pDC; macrophages M2 and M1), mucosal M-cells, NK-cells play key role for choice and development of anticancer complex procedures increasing innate and innate-coupled immune responses. Prospects of (receptor lectin)-dependent intercellular communications and targeting glycoconjugate constructions into innate immunity cells for therapy of cancer and development of anticancer vaccines are evaluated and discussed.
Subject
General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology
Reference48 articles.
1. Lakhtin M.V., Lakhtin V.M., Afanas'ev S.S., Aleshkin V.A. Lektiny: perspektivy v immunologii, mikrobiologii i biotekhnologii // Ural'skii nauchnyi vestnik. – 2017. – T. 3, № 12. – S. 25–47. Lakhtin MV, Lakhtin VM, Afanasiev SS, Aleshkin VA. (2017). Lectins: prospects in immunology, microbiology and biotechnology [Lektiny: perspektivy v immunologii, mikrobiologii i biotekhnologii]. Ural’skiy nauchnyy vestnik, 3 (12), 25-47.
2. Lakhtin M.V., Lakhtin V.M., Afanas'ev S.S., Bairakova A.L., Aleshkin V.A., Afanas'ev M.S. Kandidnye markery boleznei urogenital'nykh biotopov: reaktivnost' k lektinam probiotikov // Acta Biomedica Scientifica. – 2018. – T. 3, № 1. – S. 49–53. DOI: 10.29413/ABS.2018-3.1.7 Lakhtin MV, Lakhtin VM, Afanasiev SS, Bayrakova AL, Aleshkin VA, Afanasiev MS. (2018). Candida markers of urogenital biotopes diseases: reactivity to lectins of probiotics [Kandidnye markery bolezney urogenital’nykh biotopov: reaktivnost’ k lektinam probiotikov]. Acta Biomedica Scientifica, 3 (1), 49-53. DOI: 10.29413/ABS.2018-3.1.7
3. Alves AM, Diel LF, Lamers ML. (2017). Macrophages and prognosis of oral squamous cell carcinoma: a systematic review. J Oral Pathol Med, 47 (5), 460-467. DOI: 10.1111/jop.12643
4. Andersen MN, Andersen NF, Rødgaard-Hansen S, Hokland M, Abildgaard N, Møller HJ. (2015). The novel biomarker of alternative macrophage activation, soluble mannose receptor (sMR/sCD206): implications in multiple myeloma. Leuk Res, 39 (9), 971-975. DOI: 10.1016/j.leukres.2015.06.003
5. Boeck CL, Amberger DC, Doraneh-Gard F, Sutanto W, Guenther T, Schmohl J, Schuster F, Salih H, Babor F, Borkhardt A, Schmetzer H. (2017). Significance of frequencies, compositions, and/or antileukemic activity of (DC-stimulated) invariant NKT, NK and CIK cells on the outcome of patients with AML, ALL and CLL. J Immunother, 40 (6), 224-248. DOI: 10.1097/CJI.0000000000000171
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献